A 2024 study published in eClinicalMedicine by Buyukbabani et al. examined the effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder, utilizing an observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.

Authors

• Person: Not available Organization: Johns Hopkins Center for Psychedelic and Consciousness Research
  Published Studies — Johns Hopkins Center for Psychedelic and ...

Sources

• Published Studies — Johns Hopkins Center for Psychedelic and ... www.hopkinspsychedelic.org Johns Hopkins Center for Psychedelic and Consciousness Research via serper

Referenced by nodes (2)

• psilocybin concept
• Major Depressive Disorder concept